PATRICIA TYNAN: Open Payments
NPI 1811462310 · HUNTINGTON BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $173 · 2025 $242
Food & beverage: $242
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
Products named: Kerendia, JARDIANCE, SHINGRIX, RELISTOR, Wegovy, GVOKE HYPOPEN.
Industry payments across CA — which companies pay providers there.
